Pfizer PFE Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.76B+18.8% | $1.2B+8.1% | $1.39B+21.0% | $1.69B+50.8% | $1.48B+89.9% | ||
| $11.37B-28.4% | $12.45B-35.9% | $13.64B+54.0% | $11.61B+92.0% | $15.89B+41.7% | ||
| $12.59B+6.2% | $11.87B+3.6% | $14.26B-1.3% | $12.08B+6.0% | $11.85B+7.8% | ||
| $2.46B-11.9% | $2.37B-11.0% | $2.14B-22.5% | $2.36B-19.1% | $2.79B-16.9% | ||
| $5.71B+2.9% | $5.63B-7.7% | $6.04B-16.9% | $6.51B-7.9% | $5.55B-11.5% | ||
| $659M-21.7% | $532M-64.9% | $418M-34.0% | $367M-53.8% | $842M+7.8% | ||
| $42.82B-6.6% | $42.9B-14.8% | $46.92B+8.6% | $43.7B+15.5% | $45.86B+8.1% | ||
| $19.4B+5.8% | $19.32B+5.0% | $18.88B+1.8% | $18.78B-1.0% | $18.35B-2.4% | ||
| $17.8B+5.7% | $17.39B+5.5% | $17.51B+5.0% | $17.27B+4.2% | $16.84B+2.9% | ||
| $71.41B+4.3% | $71.26B+4.0% | $69.1B+0.8% | $69B+0.8% | $68.44B-1.2% | ||
| -$12M-101% | $2.4B+13.1% | $2.47B+14.3% | $2.48B+11.4% | $2.26B+143% | ||
| $1.87B+48.6% | $2.6B-66.9% | $2.39B+68.3% | $1.69B+73.0% | $1.26B-49.5% | ||
| $207.62B-0.2% | $208.16B-2.5% | $208.73B-4.9% | $206.1B-4.7% | $208.03B-5.9% | ||
| $4.51B-14.0% | $5.24B-7.0% | $5.02B-5.5% | $5.17B+1.2% | $5.24B-6.3% | ||
| $3.86B+3.0% | $3B-20.0% | $4.25B+13.4% | $4.25B+13.4% | $3.75B+275% | ||
| $3.13B+0.8% | $3.1B+6.6% | $3.8B+32.0% | $3.68B+27.4% | $3.11B-2.7% | ||
| $0— | $2.45B+0.3% | $0— | $2.45B+2.7% | $0— | ||
| $34.35B-5.8% | $36.98B-14.0% | $36.6B-15.3% | $37.73B-13.9% | $36.45B-10.0% | ||
| $60.57B+5.1% | $61.64B+7.4% | $57.41B-1.0% | $57.5B0.0% | $57.64B-6.0% | ||
| $14.2B+6.8% | $14.73B+4.1% | $13.61B-12.6% | $13.93B-13.4% | $13.3B-12.1% | ||
| $3.41B-97.1% | $3.25B-97.4% | $115.64B-8.9% | $117.08B-8.7% | $117.39B-8.7% | ||
| $94.77B+1.0% | $94.47B+0.9% | $94.25B+0.8% | $94.05B+0.9% | $93.86B+0.9% | ||
| $117.24B-2.0% | $114.61B-1.8% | $121.15B+0.1% | $117.61B+0.9% | $119.59B-1.4% | ||
| -$7.2B+16.1% | -$8.07B-2.9% | -$8.07B-1.2% | -$8.44B-8.0% | -$8.58B-10.6% | ||
| $115.19B+0.2% | $115.02B+0.2% | $115.01B+0.2% | $115.01B+0.2% | $115.01B+0.2% | ||
| $90.1B-0.3% | $86.48B-2.0% | $92.8B+0.6% | $88.7B+1.1% | $90.34B-2.1% | ||
| $207.62B-0.2% | $208.16B-2.5% | $208.73B-4.9% | $206.1B-4.7% | $208.03B-5.9% | ||
| $425M-0.5% | $427M-2.5% | $434M-6.7% | $439M-6.2% | $427M-10.9% | ||
| $8.19B-41.3% | $9.18B-15.6% | $10.12B+47.8% | $9.53B+116% | $13.95B+69.8% | ||
| $504M— | $416M— | —— | —— | —— | ||
| $4.03B-3.1% | $4.11B+9.0% | $4.49B+36.7% | $4.13B+28.1% | $4.16B+19.2% | ||
| $923M-18.8% | $907M-7.1% | $945M-19.5% | $1.03B-11.0% | $1.14B+0.8% | ||
| $2.91B-1.3% | $2.81B-34.0% | $2.36B-38.8% | $2.69B-35.8% | $2.95B-32.6% | ||
| $29M-94.9% | —— | $56M-56.6% | $43M-85.1% | $564M+106% | ||
| $9.55B— | $9.91B— | —— | —— | —— | ||
| $504M— | $416M— | —— | —— | —— | ||
| $41M-91.6% | $116M— | $60M-42.3% | $42M-85.1% | $487M+94.0% | ||
| $9.55B-36.1% | $9.91B-16.2% | $11.54B+49.2% | $10.36B+87.9% | $14.94B+63.1% | ||
| $9.83B-0.1% | $9.63B-1.9% | $9.32B-11.1% | $9.46B-11.7% | $9.85B-12.1% | ||
| $155M— | $116M— | —— | —— | —— | ||
| $444M+11.0% | —— | $467M+44.6% | $435M+42.2% | $400M+36.5% | ||
| $225M+0.9% | —— | $239M+20.7% | $239M+11.7% | $223M+5.2% | ||
| $653M-36.7% | $642M-48.5% | $1.18B-14.0% | $1.12B-49.4% | $1.03B-59.5% | ||
| $21.64B+11.8% | $22.22B+13.6% | $17.81B-21.4% | $18.67B-17.5% | $19.35B-15.6% | ||
| $21.64B+11.8% | $22.22B+13.6% | $17.81B-21.4% | $18.67B-17.5% | $19.35B-15.6% | ||
| $21.64B+11.8% | $22.22B+13.6% | $17.81B-21.4% | $18.67B-17.5% | $19.35B-15.6% | ||
| $21.64B+11.8% | $22.22B+13.6% | $17.81B-21.4% | $18.67B-17.5% | $19.35B-15.6% | ||
| $0— | $1M— | $1M-83.3% | $1M-98.6% | —— | ||
| $9.97B+4.4% | $9.7B+12.0% | $11.05B+39.7% | $10.34B+31.5% | $9.54B+93.1% | ||
| $30.92B-10.7% | $31.51B-12.1% | $33.51B-10.2% | $34.03B-11.8% | $34.62B-13.2% | ||
| $47M0.0% | $48M+6.7% | $48M+2.1% | $48M-11.1% | $47M+4.4% | ||
| $52.56B-2.6% | $53.73B-3.0% | $51.32B-14.4% | $52.7B-13.9% | $53.98B-14.1% | ||
| $9.83B-0.1% | $9.63B-1.9% | $9.32B-11.1% | $9.46B-11.7% | $9.85B-12.1% | ||
| $1.63B-9.1% | $1.62B-27.2% | $2.14B-2.0% | $1.9B-39.2% | $1.79B-48.7% | ||
| $3.59B+23.7% | $3.97B+19.7% | $3.86B+18.9% | $4.02B+8.7% | $2.9B-31.5% | ||
| $1.63B-9.1% | $1.62B-27.2% | $2.14B-2.0% | $1.9B-39.2% | $1.79B-48.7% | ||
| $9.83B-0.1% | $9.63B-1.9% | $9.32B-11.1% | $9.46B-11.7% | $9.85B-12.1% | ||
| $2.72B+4.1% | $3.61B-5.9% | $3.04B-10.3% | $2.45B-4.6% | $2.61B+18.9% | ||
| $2.72B+4.1% | $3.61B-5.9% | $3.04B-10.3% | $2.45B-4.6% | $2.61B+18.9% | ||
| $20.11B+0.5% | $19.43B-1.5% | $19.51B-2.0% | $18.58B+13.2% | $20.02B+6.5% | ||
| $29M-94.9% | $157M-79.2% | $56M-65.0% | $50M-84.4% | $567M+56.6% | ||
| $1.37B+3.9% | $1.46B+6.7% | $1.58B+4.6% | $1.91B+55.6% | $1.31B+14.7% | ||
| $518M-5.1% | $574M-16.6% | $566M-9.9% | $501M-15.5% | $546M-17.0% | ||
| $3.89B-12.9% | $3.16B-54.6% | $4.31B-55.8% | $4.3B-64.3% | $4.47B-46.1% | ||
| $3.71B-35.3% | $3.59B-41.2% | $3.4B-42.4% | $3.31B-49.3% | $5.72B-33.5% | ||
| $1.98B-1.8% | $2.04B-3.5% | $2.16B+4.1% | $2.13B+4.4% | $2.02B-2.6% | ||
| $29M-25.6% | $3M-62.5% | $2M-96.4% | $87M+1,350% | $39M+1,850% | ||
| $2M-94.4% | $35M-72.9% | $24M+700% | $1M-85.7% | $36M-53.8% | ||
| $482M+0.2% | $481M+0.2% | $481M+0.2% | $481M+0.2% | $481M+0.2% | ||
| $1.37B+3.9% | $1.46B+6.7% | $1.58B+4.6% | $1.91B+55.6% | $1.31B+14.7% | ||
| $425M-0.5% | $427M-2.5% | $434M-6.7% | $439M-6.2% | $427M-10.9% | ||
| $1.95B— | $1.7B— | —— | —— | —— | ||
| $95M— | $95M— | —— | —— | —— | ||
| $1.2B+87.5% | —— | $1.2B+30.9% | $1.1B+44.0% | $640M-16.6% | ||
| $3.89B-13.0% | $3.15B-54.6% | $4.3B-55.6% | $4.3B-64.0% | $4.47B-45.7% | ||
| $3M+200% | $3M-75.0% | $3M-94.2% | $4M-95.6% | $1M-98.4% | ||
| $9.53B-36.2% | $9.94B-16.7% | $11.56B+50.5% | $10.28B+86.3% | $14.94B+61.8% | ||
| $38M+81.0% | —— | $33M+57.1% | $34M+54.5% | $21M+50.0% | ||
| $9.51B-36.2% | —— | $11.49B+49.6% | $10.31B+91.3% | $14.89B+65.9% | ||
| $10M-61.5% | —— | $16M-51.5% | $14M-86.1% | $26M-84.5% | ||
| $2.41B+6.8% | $2.4B+13.1% | $2.47B+14.3% | $2.48B+11.4% | $2.26B+143% | ||
| $155M— | $116M— | —— | —— | —— | ||
| $1.37B+3.9% | $1.46B+6.7% | $1.58B+4.6% | $1.91B+55.6% | $1.31B+14.7% | ||
| $1.1B+70.3% | —— | $1.1B+20.9% | $1.1B+41.9% | $646M-16.1% | ||
| $237M+5.8% | $235M+8.3% | $223M-97.4% | $224M-97.2% | $224M-97.2% | ||
| $147M— | $146M— | —— | —— | —— | ||
| $2.04B+328% | $1.79B+246% | —— | —— | $477M— | ||
| $73.86B+7.4% | $72.5B+7.3% | $71.34B+7.3% | $70.52B+7.9% | $68.78B+7.2% | ||
| $104.78B+1.3% | $104.01B+0.6% | $104.85B+1.0% | $104.55B+0.6% | $103.4B-0.6% | ||
| $803M— | $821M— | —— | —— | —— | ||
| $8.43B— | $7.11B— | —— | —— | —— | ||
| -$248M— | -$163M— | —— | —— | —— | ||
| $21.64B+11.8% | $22.22B+13.6% | $17.81B-21.4% | $18.67B-17.5% | $19.35B-15.6% | ||
| $126.42B+3.0% | $126.23B+2.7% | $122.66B-3.0% | $123.22B-2.7% | $122.75B-3.3% | ||
| $379M— | $523M— | —— | —— | —— | ||
| $3.03B— | $2.73B— | —— | —— | —— | ||
| $950M— | $999M— | —— | —— | —— | ||
| $3.86B+3.0% | $3B-20.0% | $4.25B+13.3% | $4.25B+13.3% | $3.75B+275% | ||
| $303M+1.3% | $299M+1.7% | $295M+8.5% | $317M+15.3% | $299M+8.3% | ||
| $1.11B— | $1.12B— | —— | —— | —— | ||
| $688M-3.4% | $696M-3.2% | $690M-9.1% | $729M-7.3% | $712M-6.9% | ||
| $11.55B+5.5% | $11.67B+7.8% | $12.94B+7.0% | $11.67B+24.1% | $10.95B+29.1% | ||
| $1.59B-33.8% | $1.91B-9.9% | $1.84B-13.9% | $1.99B-17.2% | $2.4B+46.5% | ||
| $1M0.0% | —— | $1M0.0% | $1M0.0% | $1M0.0% | ||
| $15B0.0% | —— | $15B0.0% | $15B0.0% | $15B0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pfizer's total assets?
- Pfizer (PFE) holds $207.62B in total assets, down 0.2% year over year.
- How much debt does Pfizer have?
- Pfizer carries $64.4B in total debt against $90.1B of shareholders' equity, a debt-to-equity ratio of 0.71.
- How much cash does Pfizer have?
- Pfizer holds $1.8B in cash and equivalents.
- Can Pfizer cover its short-term obligations?
- Its current ratio is 1.25 — current assets exceed current liabilities.
- Where does Pfizer's balance sheet data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
